Workflow
WORK Medical Technology Group Ltd(WOK)
icon
Search documents
沃氪医疗上涨3.72%,报0.8美元/股,总市值4522.77万美元
Jin Rong Jie· 2025-08-18 13:53
Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.72% on August 18, reaching $0.8 per share, with a total market capitalization of $45.23 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]
沃氪医疗上涨2.5%,报0.8美元/股,总市值4522.77万美元
Jin Rong Jie· 2025-08-14 13:43
Core Viewpoint - Wok Medical (WOK) experienced a 2.5% increase in stock price, reaching $0.8 per share, with a total market capitalization of $45.23 million as of August 14 [1] Financial Performance - For the fiscal year ending September 30, 2024, Wok Medical reported total revenue of $11.51 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which represents a significant year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables, including anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]
沃氪医疗上涨3.24%,报0.793美元/股,总市值4483.19万美元
Jin Rong Jie· 2025-08-05 16:44
Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.24% on August 6, reaching $0.793 per share, with a total market capitalization of $44.83 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]
沃氪医疗上涨10.66%,报0.85美元/股,总市值4805.44万美元
Jin Rong Jie· 2025-08-05 13:52
Core Viewpoint - Wok Medical (WOK) experienced a significant stock price increase of 10.66% on August 5, reaching $0.85 per share, with a total market capitalization of $48.05 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to the parent of -$3.4923 million, which represents a staggering year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]
沃氪医疗上涨4.29%,报0.85美元/股,总市值4805.44万美元
Jin Rong Jie· 2025-07-29 14:03
Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 4.29% on July 29, reaching $0.85 per share, with a total market capitalization of $48.05 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.4923 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
GlobeNewswire News Room· 2025-05-22 21:30
Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and other subsidiaries [8] - The company develops and manufactures Class I and II medical devices, including customized and multifunctional masks, and sells disposable medical devices [8] - WORK Medical Technology has a diverse product portfolio comprising 21 products, with sales in 34 provincial-level administrative regions in China and exports to over 30 countries [8] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [8] Offering Details - The company closed a registered offering, selling an aggregate of 10,000,000 ordinary units at an offering price of $0.50 per unit, resulting in gross proceeds of approximately $5 million [2][4] - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [3] - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months, and both are immediately exercisable upon issuance [3] Underwriting and Regulatory Compliance - Univest Securities, LLC acted as the sole book-running manager for the offering [4] - The offering was made pursuant to a registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission [5]
WORK Medical Technology Group LTD Announces Closing of Registered Offering
Globenewswire· 2025-05-22 20:10
Core Viewpoint - WORK Medical Technology Group LTD has successfully closed a registered offering of 10,000,000 ordinary units at a price of $0.50 per unit, raising a total of $5.0 million before expenses [1][3]. Summary by Sections Offering Details - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [2]. - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months [2]. - The offering was conducted on a firm commitment basis, with Univest Securities, LLC serving as the sole book-running manager [4]. Use of Proceeds - Proceeds from the offering will be allocated for upgrading production equipment, investing in research and development, hiring experienced employees for compliance improvements, and general corporate purposes [3]. Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [6]. - The company has a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [6]. - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA for market entry in the U.S. [6].
WORK Medical Technology Group LTD Announces Pricing of Registered Offering
Globenewswire· 2025-05-21 13:00
Core Viewpoint - WORK Medical Technology Group LTD is conducting a registered offering of 10,000,000 ordinary and pre-funded units to raise funds for various corporate purposes, including upgrading production equipment and R&D investments [1][3]. Group 1: Offering Details - The offering price is set at $0.50 per Ordinary Unit and $0.4995 per Pre-funded Unit [1]. - Each Ordinary Unit includes one Class A ordinary share, one Series A warrant, and one Series B warrant, while each Pre-funded Unit consists of one pre-funded warrant, one Series A warrant, and one Series B warrant [2]. - The Company expects to receive gross proceeds of $5.0 million from the offering before deducting expenses [3]. Group 2: Use of Proceeds - Proceeds will be allocated for upgrading production equipment, investing in R&D, hiring experienced employees for compliance improvements, and general corporate purposes [3]. Group 3: Company Overview - WORK Medical is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices, with a diverse product portfolio of 21 products [6]. - The Company has sold products in 34 provincial-level regions in China and in over 30 countries globally, with 17 products registered with the U.S. FDA [6].
WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Newsfilter· 2025-04-11 20:01
Core Viewpoint - WORK Medical Technology Group LTD has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market [1][2]. Company Compliance Status - Nasdaq Listing Rule 5550(a)(2) mandates a minimum bid price of US$1.00 per share, and the company failed to meet this requirement for 30 consecutive business days from February 24, 2025, to April 4, 2025 [2]. - The company has until October 6, 2025, to regain compliance by ensuring its Class A ordinary shares have a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days [3]. Business Operations - The receipt of the Notification Letter does not impact the company's business operations [3]. - The company plans to monitor its share price and may consider options such as a reverse share split to regain compliance with Nasdaq's minimum bid price requirement [4]. Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company's products are sold in 34 provincial-level regions in China and in over 30 countries worldwide, with 17 products registered with the U.S. Food and Drug Administration [5].
WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
Newsfilter· 2025-03-05 21:01
Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China [2] - The company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables [2] - All products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide [2] - The company has received several quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing their products to enter the U.S. market [2] Recent Developments - The company announced the implementation of its dual-class share structure, effective March 6, 2025 [1]